Literature DB >> 27659900

Guillain-Barré syndrome: What have we learnt during one century? A personal historical perspective.

A Uncini1.   

Abstract

We are approaching the centenary of the first description of Guillain-Barré syndrome. The past 30 years had witnessed an amazing progress in the understanding of the immunological and pathological mechanisms of this disorder. We now recognize that Guillain-Barré syndrome is remarkably heterogeneous and under this umbrella term are several variants and subtypes with distinct clinical, electrophysiological and immunopathological features. This review is a historical journey, through a personal perspective, following the milestones that led to the current substantial knowledge of Guillain-Barré syndrome.
Copyright © 2016 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Acute inflammatory demyelinating neuropathy; Acute motor axonal neuropathy; Anti-gangliosides antibodies; Campylobacter jejuni; Electrodiagnosis; Guillain-Barré syndrome

Mesh:

Year:  2016        PMID: 27659900     DOI: 10.1016/j.neurol.2016.08.006

Source DB:  PubMed          Journal:  Rev Neurol (Paris)        ISSN: 0035-3787            Impact factor:   2.607


  2 in total

1.  Guillain-Barré or Guillain-Barré-Strohl syndrome: medical and non-medical reasons for omitting Andre Strohl from the eponym.

Authors:  Łukasz Rzepiński; Andrzej Grzybowski
Journal:  Arch Med Sci       Date:  2022-06-23       Impact factor: 3.707

2.  Altered serum levels of IL-36 cytokines (IL-36α, IL-36β, IL-36γ, and IL-36Ra) and their potential roles in Guillain-Barré syndrome.

Authors:  Zhikang Zhao; Rui Zhang; Xinxin Gao; Hui Li; Hongbo Liu
Journal:  Medicine (Baltimore)       Date:  2020-12-24       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.